Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2017 Scientific Sessions in San Diego, CA.
Dr. Jim McDermott is Vice President of US Medical Affairs for Diabetes at AstraZeneca. He has been with AstraZeneca for more than two decades.
Featured videos include:
Pt.1: AstraZeneca SGLT2 Trials
Pt.2: Efficacy Of SGLT2 Inhibitors
Pt.3: Results From The Duration 8-Study
Pt.4: SGLT2 Effects On Patients
Pt.5: AstraZeneca DapaCare
Pt.6: SGLT2 Cardiovascular Trials
or view the complete interview here: Complete Interview.